Change of administration route of allergen immunotherapy: Rates and causes

• Cristina Rivas Juesas ^[1] ; Ana Delgado Vicente ^[1]
  1. [1] Paediatrics Department, Sagunto Hospital, Port de Sagunt, Valencia, Spain
• Localización: Allergologia et immunopathologia: International journal for clinical and investigate allergology and clinical immunology, ISSN-e 1578-1267, ISSN 0301-0546, Vol. 53, Nº. 2, 2025, págs. 10-12
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Allergen immunotherapy (AIT) has shown efficacy in the short and the long term in the management of allergic respiratory diseases, and it’s administered subcutaneously (subcu-taneous immunotherapy, or SCIT) or sublingually (sublingual immunotherapy, or SLIT), being both effective and safe options.